Peptides DB
Research-centric peptide and protocol reference hub
Study 50 of 56Oxytocin literatureNeuroendocrinology · Observational2026

Butyrate enhances the obesity reduction effect of Semaglutide.

Butyrate may enhance the weight loss effects of semaglutide in mice, but the relevance to human obesity treatment is unclear.

Read at NeuroendocrinologyAdd to compare

Where it sits

this study against the rest of the oxytocin corpus
2
Preclinical
39
Observational · this one
0
Open-label
8
Randomised
7
Reviews

Summary and findings

This study evaluated the effects of oxytocin, long-acting oxytocin, caffeine, and butyrate on the anti-obesity efficacy of semaglutide in diet-induced obese mice. Butyrate was found to significantly enhance the body weight reduction effects of semaglutide. The study also compared hypothalamic neuronal activity and plasma metabolomic profiles following treatment.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as Neuroendocrinology supplied them

<h4>Background</h4>Obesity represents a global public health burden with continuously increasing prevalence over recent decades. Combination regimens pairing semaglutide (Sema) with additional therapeutic agents have emerged as a major focus for anti-obesity research.<h4>Methods</h4>In diet-induced obese (DIO) mice, we evaluated whether oxytocin (Oxt, 3 and 5 mg·kg-1), long-acting oxytocin (la‑Oxt), caffeine, or butyrate could potentiate the anti-obesity efficacy of Sema. We further compared hypothalamic neuronal activity and plasma metabolomic profiles following Sema treatment against dietary restriction (DR), an established intervention for weight loss and metabolic improvement.<h4>Results</h4>Whereas Oxt, la‑Oxt, and caffeine did not augment Sema-mediated body weight reduction, butyrate produced significant potentiation of Sema's anti-obesity effects. Either Sema monotherapy or Sema-butyrate co-administration elevated the number of c-Fos-positive cells in the paraventricular nucleus (PVN) of the hypothalamus. By contrast, DR decreased PVN c-Fos-positive cell number. Butyrate amplified Sema-elicited activation of PVN neuronal activity. Plasma metabolomics revealed limited overlap between the pharmacological interventions and DR, demonstrating orthogonal metabolic responses.<h4>Conclusions</h4>These findings identify the Sema-butyrate combination as a promising anti-obesity strategy, and demonstrate that Sema and DR exert divergent effects on both hypothalamic neuronal activity and plasma metabolite levels.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Oxytocin corpus

CThe corpus luteum transcriptome is dysregulated in dairy cows with mastitis.Theriogenology · 2026 · n=17 · 428 differentially expressed genes (DEG) between CLM and CON cows, FDR < 0.05AnimalBSpatiotemporal mapping of ex vivo myometrial contractions in adenomyosisbiorxiv-preprint · 2026 · Adenomyosis patients had a 1.8-fold higher oxytocin receptor density.HumanCSensory context gates oxytocin effects on auditory processing in macaquesbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCRepeated linalyl acetate inhalation attenuates the stress-evoked immediate-early gene programme in the mouse hippocampus and olfactory bulb: a reanalysis of public transcriptomic databiorxiv-preprint · 2023 · n=9 · 21 of 22 detected IEGs decreased in the hippocampus after LA inhalation, label-permutation P = 0.012.AnimalDA Hypothalamic Oxytocinergic-Sympathetic Axis Couples Anxiety Dysregulation With Impaired Tendon-Bone Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026 · Not reported in abstract.reviewDStage- and context-dependent modulation of fear memory by oxytocin: Neurobiological mechanisms and implications for PTSD.Neuroscience and biobehavioral reviews · 2026 · Not reported in abstract.review